Nicotinamide riboside for use in treating or preventing liver damage
US11389468B2 · kind B2 · utility
1Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2018 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Aug 25, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.